Therapeutic Expertise

Clinical trials in therapeutic areas that launch your journey

  • Oncology CoE brochure single page

    Oncology CoE brochure single page

    Read More
  • Crafting a genomics strategy early is key for successful oncology drug development

    Crafting a genomics strategy early is key for successful oncology drug development

    Read More
  • ×

    Speak to a Parexel® Biotech expert today!

    First Name
    Last Name
    Job Title
    Company Name
    Country
    Tell us how we can help
    Thank you!
    Error - something went wrong!
  • World Cancer Day Roundtable with Parexel Oncology Experts14:07

    World Cancer Day Roundtable with Parexel Oncology Experts

    Watch Video
  • Rare Disease factsheet

    Rare Disease factsheet

    Read More
  • FOUR TRENDS THAT WILL GUIDE THE FUTURE OF DRUG DEVELOPMENT IN ONCOLOGY

    FOUR TRENDS THAT WILL GUIDE THE FUTURE OF DRUG DEVELOPMENT IN ONCOLOGY

    Read More
  • ×

    Tell Us About Your Biotech Goals.

    What are your top priorities for 2019?
    Thank you!
    Error - something went wrong!
  • CAR T-Cell Therapies Pose A New Development Model and Demand New Skill Sets

    CAR T-Cell Therapies Pose A New Development Model and Demand New Skill Sets

    Read More
  • Rare Disease Infographic

    Rare Disease Infographic

    Managing rare disease studies requires a very different approach.

    Read More
  • Challenging Conventional Patient Recruitment And Care Strategies For Rare Disease Studies

    Challenging Conventional Patient Recruitment And Care Strategies For Rare Disease Studies

    Read this article to find out more about orphan diseases.

    Read More
  • Three Important Considerations of Cardiovascular Outcomes Trials

    Three Important Considerations of Cardiovascular Outcomes Trials

    Infographic:Consider these three important strategies prior to conducting Cardiovascular Outcomes Trials.

    Read More
  • Venturing Into a New Era of CNS Drug Development to Improve Success

    Venturing Into a New Era of CNS Drug Development to Improve Success

    Three strategies that apply multidisciplinary solutions earlier in the development process to reduce failures and accelerate CNS drug development.

    Read More
  • Faster Is The New Normal In Oncology Drug Development

    Faster Is The New Normal In Oncology Drug Development

    Learn five risk-mitigation strategies to produce data-rich trials, better teamwork and more regulatory interaction.

    Read More
  • Behind the Breakthrough: How the FDAs Breakthrough Designation Changes a Trial

    Behind the Breakthrough: How the FDAs Breakthrough Designation Changes a Trial

    Learn more about the most coveted of expedited pathways.

    Read More
  • The Past Present and Future of Cancer Immunotherapy

    The Past Present and Future of Cancer Immunotherapy

    Learn five strategies for accelerating future successes in cancer immunotherapy.

    Read More
  • Starting Stronger In Phase I Through IIA

    Starting Stronger In Phase I Through IIA

    From First-in-Human (FiH) through Proof-of-Concept (PoC), our Early Phase Services help you set a solid foundation so that you have a better chance of achieving success.

    Read More
  • Challenging Conventional Patient Recruitement and Care Strategies for Orphan Disease Studies

    Challenging Conventional Patient Recruitement and Care Strategies for Orphan Disease Studies

    Challenge conventional patient recruitment methods and care strategies to successfully recruit patients for orphan disease studies.

    Read More
  • Accelerated Pathways: Global Opportunities and Challenges for Innovators

    Accelerated Pathways: Global Opportunities and Challenges for Innovators

    Navigate the opportunities and challenges accelerated pathways present with these key strategies.

    Read More
  • World Class Early Phase Clinical Units:Infographic

    World Class Early Phase Clinical Units:Infographic

    Global Capabilities to Ensure Your Study’s Efficiency, Quality and Safety.

    Read More
  • London EPCU Fact Sheet

    London EPCU Fact Sheet

    Highest level of accreditation from the UK Medicines and Healthcare Regulatory Agency for Phase I clinical study units to carry out studies with compounds at all levels of risk.

    Read More
  • Berlin EPCU Fact Sheet

    Berlin EPCU Fact Sheet

    In-house scientific and medical expertise, combined with the latest in clinical and research technology.

    Read More
  • Los Angeles EPCU Fact Sheet

    Los Angeles EPCU Fact Sheet

    One of the world’s largest Japanese Phase I units. Pioneered the conduct of Asian (Japanese, Chinese and Korean) ethnobridging studies outside of Asia in 2001.

    Read More
  • loading
    Loading More...